Filing Details

Accession Number:
0001209191-13-029528
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-30 14:47:01
Reporting Period:
2013-05-28
Filing Date:
2013-05-30
Accepted Time:
2013-05-30 14:47:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Pharmaceuticals Inc. PCRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1134657 Luke Evnin C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-05-28 114,837 $30.62 1,061,535 No 4 S Indirect See Footnote
Common Stock Disposition 2013-05-28 74,980 $31.38 986,555 No 4 S Indirect See Footnote
Common Stock Disposition 2013-05-28 5,300 $32.14 981,255 No 4 S Indirect See Footnote
Common Stock Disposition 2013-05-29 20,411 $30.00 960,844 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 22,746 Direct
Footnotes
  1. This transaction was pursuant to a 10b5-1 Plan.
  2. The shares were sold as follows: 107,625 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 4,146 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG") and 3,066 by MPM Asset Management Investors BV4 LLC ("AM BV4"). MPM BioVentures IV GP LLC and MPM BioVentures IV LLC ("BV LLC") are the direct and indirect general partners of BV IV QP and BV IV KG and BV LLC is the manager of AM BV4. The Reporting Person is a member of BV LLC.
  3. Represents the average sales price. The shares were sold between $30.00 and $31.00. The Reporting Person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. The shares are held as follows: 994,948 by BV IV QP, 38,334 by BV IV KG and 28,253 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  5. The shares were sold as follows: 70,271 by BV IV QP, 2,707 by BV IV KG and 2,002 by AM BV4.
  6. Represents the average sales price. The shares were sold between $31.01 and $32.01. The Reporting Person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  7. The shares are held as follows: 924,677 by BV IV QP, 35,627 by BV IV KG and 26,251 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  8. The shares were sold as follows: 4,968 by BV IV QP, 191 by BV IV KG and 141 by AM BV4.
  9. Represents the average sales price. The shares were sold between $32.12 and $32.33. The Reporting Person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  10. The shares are held as follows: 919,709 by BV IV QP, 35,436 by BV IV KG and 26,110 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  11. The shares were sold as follows: 19,129 by BV IV QP, 737 by BV IV KG and 545 by AM BV4.
  12. The shares are held as follows: 900,580 by BV IV QP, 34,699 by BV IV KG and 25,565 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.